| Net Cash Provided by (Used in) Operating Activities |
$153,238 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$384,089 |
USD |
-60% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
-88% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,892,960 |
shares |
-97% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$153,238 |
USD |
-349% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$41,941 |
USD |
-90% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,824,029 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$54,044 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$57,494 |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$39,744 |
USD |
89% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$3,620 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$43,332 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$3,450 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,824,029 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$10,405,395 |
USD |
3.8% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$22,838 |
USD |
-2.8% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$244,705 |
USD |
100% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |